Parmar Paresh A, St-Pierre Jean-Philippe, Chow Lesley W, Spicer Christopher D, Stoichevska Violet, Peng Yong Y, Werkmeister Jerome A, Ramshaw John A M, Stevens Molly M
Department of Materials, Imperial College London, Exhibition Road, London SW7 2AZ, United Kingdom; Department of Bioengineering, Imperial College London, Exhibition Road, London SW7 2AZ, United Kingdom; Institute of Biomedical Engineering, Imperial College London, Exhibition Road, London SW7 2AZ, United Kingdom; CSIRO Manufacturing, Bayview Avenue, Clayton, Victoria 3169, Australia; Division of Biomaterials and Regenerative Medicine, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Scheeles väg 2, 17177 Stockholm, Sweden.
Department of Materials, Imperial College London, Exhibition Road, London SW7 2AZ, United Kingdom; Department of Bioengineering, Imperial College London, Exhibition Road, London SW7 2AZ, United Kingdom; Institute of Biomedical Engineering, Imperial College London, Exhibition Road, London SW7 2AZ, United Kingdom.
Acta Biomater. 2017 Mar 15;51:75-88. doi: 10.1016/j.actbio.2017.01.028. Epub 2017 Jan 10.
Recapitulation of the articular cartilage microenvironment for regenerative medicine applications faces significant challenges due to the complex and dynamic biochemical and biomechanical nature of native tissue. Towards the goal of biomaterial designs that enable the temporal presentation of bioactive sequences, recombinant bacterial collagens such as Streptococcal collagen-like 2 (Scl2) proteins can be employed to incorporate multiple specific bioactive and biodegradable peptide motifs into a single construct. Here, we first modified the backbone of Scl2 with glycosaminoglycan-binding peptides and cross-linked the modified Scl2 into hydrogels via matrix metalloproteinase 7 (MMP7)-cleavable or non-cleavable scrambled peptides. The cross-linkers were further functionalized with a tethered RGDS peptide creating a system whereby the release from an MMP7-cleavable hydrogel could be compared to a system where release is not possible. The release of the RGDS peptide from the degradable hydrogels led to significantly enhanced expression of collagen type II (3.9-fold increase), aggrecan (7.6-fold increase), and SOX9 (5.2-fold increase) by human mesenchymal stem cells (hMSCs) undergoing chondrogenesis, as well as greater extracellular matrix accumulation compared to non-degradable hydrogels (collagen type II; 3.2-fold increase, aggrecan; 4-fold increase, SOX9; 2.8-fold increase). Hydrogels containing a low concentration of the RGDS peptide displayed significantly decreased collagen type I and X gene expression profiles, suggesting a major advantage over either hydrogels functionalized with a higher RGDS peptide concentration, or non-degradable hydrogels, in promoting an articular cartilage phenotype. These highly versatile Scl2 hydrogels can be further manipulated to improve specific elements of the chondrogenic response by hMSCs, through the introduction of additional bioactive and/or biodegradable motifs. As such, these hydrogels have the possibility to be used for other applications in tissue engineering.
Recapitulating aspects of the native tissue biochemical microenvironment faces significant challenges in regenerative medicine and tissue engineering due to the complex and dynamic nature of the tissue. The ability to take advantage of, mimic, and modulate cell-mediated processes within novel naturally-derived hydrogels is of great interest in the field of biomaterials to generate constructs that more closely resemble the biochemical microenvironment and functions of native biological tissues such as articular cartilage. Towards this goal, the temporal presentation of bioactive sequences such as RGDS on the chondrogenic differentiation of human mesenchymal stem cells is considered important as it has been shown to influence the chondrogenic phenotype. Here, a novel and versatile platform to recreate a high degree of biological complexity is proposed, which could also be applicable to other tissue engineering and regenerative medicine applications.
由于天然组织复杂且动态的生化和生物力学特性,在再生医学应用中重现关节软骨微环境面临重大挑战。为了实现能够适时呈现生物活性序列的生物材料设计目标,可以采用重组细菌胶原蛋白,如链球菌胶原样2(Scl2)蛋白,将多个特定的生物活性和可生物降解的肽基序整合到单个构建体中。在此,我们首先用糖胺聚糖结合肽修饰Scl2的主链,并通过基质金属蛋白酶7(MMP7)可切割或不可切割的乱序肽将修饰后的Scl2交联成水凝胶。交联剂进一步用连接的RGDS肽进行功能化,创建了一个系统,通过该系统可以将从MMP7可切割水凝胶中的释放与无法释放的系统进行比较。RGDS肽从可降解水凝胶中的释放导致正在进行软骨形成的人间充质干细胞(hMSCs)中II型胶原蛋白(增加3.9倍)、聚集蛋白聚糖(增加7.6倍)和SOX9(增加5.2倍)的表达显著增强,与不可降解水凝胶相比,细胞外基质积累也更多(II型胶原蛋白;增加3.2倍,聚集蛋白聚糖;增加4倍,SOX9;增加2.8倍)。含有低浓度RGDS肽的水凝胶显示I型和X型胶原蛋白基因表达谱显著降低,这表明在促进关节软骨表型方面,它比用更高浓度RGDS肽功能化的水凝胶或不可降解水凝胶具有主要优势。这些高度通用的Scl2水凝胶可以通过引入额外的生物活性和/或可生物降解基序进一步进行调控,以改善hMSCs软骨形成反应的特定元素。因此,这些水凝胶有可能用于组织工程的其他应用。
由于组织的复杂和动态性质,在再生医学和组织工程中重现天然组织生化微环境的各个方面面临重大挑战。在新型天然衍生水凝胶中利用、模拟和调节细胞介导过程的能力在生物材料领域引起了极大兴趣,以生成更类似于关节软骨等天然生物组织的生化微环境和功能的构建体。为了实现这一目标,RGDS等生物活性序列在人间充质干细胞软骨分化过程中的适时呈现被认为很重要,因为它已被证明会影响软骨形成表型。在此,提出了一个新颖且通用的平台,用于重现高度的生物复杂性,该平台也可应用于其他组织工程和再生医学应用。